US5225192A
(en)
*
|
1988-10-17 |
1993-07-06 |
Vectorpharma International S.P.A. |
Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate
|
DE3775054D1
(de)
*
|
1987-06-16 |
1992-01-16 |
Akzo Nv |
Zweikammer-spritze und herstellungsverfahren.
|
JPH09510461A
(ja)
*
|
1994-03-24 |
1997-10-21 |
ベーリンガー インゲルハイム アグロベット アー/エス |
薬剤又は栄養剤を動物に投与するための粒状生成物を含む投薬ユニット及び粒状生成物の製造方法
|
SE9602644D0
(sv)
*
|
1996-07-04 |
1996-07-04 |
Astra Ab |
New use
|
US8603511B2
(en)
|
1996-08-27 |
2013-12-10 |
Baxter International, Inc. |
Fragmented polymeric compositions and methods for their use
|
US8303981B2
(en)
|
1996-08-27 |
2012-11-06 |
Baxter International Inc. |
Fragmented polymeric compositions and methods for their use
|
US6066325A
(en)
|
1996-08-27 |
2000-05-23 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
US7871637B2
(en)
|
1996-08-27 |
2011-01-18 |
Baxter International Inc. |
Dry hemostatic compositions and methods for their preparation
|
US7435425B2
(en)
*
|
2001-07-17 |
2008-10-14 |
Baxter International, Inc. |
Dry hemostatic compositions and methods for their preparation
|
AU742787B2
(en)
|
1997-07-09 |
2002-01-10 |
Androsolutions, Inc. |
Improved methods and compositions for treating male erectile dysfunction
|
US6103765A
(en)
|
1997-07-09 |
2000-08-15 |
Androsolutions, Inc. |
Methods for treating male erectile dysfunction
|
US6593369B2
(en)
|
1997-10-20 |
2003-07-15 |
Vivus, Inc. |
Methods, compositions, and kits for enhancing female sexual desire and responsiveness
|
US20050070516A1
(en)
*
|
1997-10-28 |
2005-03-31 |
Vivus Inc. |
As-needed administration of an androgenic agent to enhance female desire and responsiveness
|
US5877216A
(en)
*
|
1997-10-28 |
1999-03-02 |
Vivus, Incorporated |
Treatment of female sexual dysfunction
|
AU740758B2
(en)
|
1997-10-28 |
2001-11-15 |
Vivus, Inc. |
Treatment of female sexual dysfunction
|
ES2299439T3
(es)
*
|
1999-10-22 |
2008-06-01 |
Antares Pharma, Inc. |
Cartucho de medicamento y dispositivo de inyeccion.
|
US6264987B1
(en)
*
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
US6495164B1
(en)
*
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US6471995B1
(en)
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
EP1465596A1
(en)
*
|
2002-01-18 |
2004-10-13 |
Control Delivery Systems, Inc. |
Polymeric gel system for the controlled delivery of codrugs
|
WO2003068290A2
(en)
|
2002-02-11 |
2003-08-21 |
Antares Pharma, Inc. |
Intradermal injector
|
GB0222522D0
(en)
|
2002-09-27 |
2002-11-06 |
Controlled Therapeutics Sct |
Water-swellable polymers
|
US20050181030A1
(en)
*
|
2003-01-03 |
2005-08-18 |
Mo Y. J. |
Topical stabilized prostaglandin E compound dosage forms
|
US6841574B2
(en)
*
|
2003-01-03 |
2005-01-11 |
Nexmed Holdings, Inc. |
Topical stabilized prostaglandin E compound dosage forms
|
US8834864B2
(en)
*
|
2003-06-05 |
2014-09-16 |
Baxter International Inc. |
Methods for repairing and regenerating human dura mater
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
MXPA06011924A
(es)
*
|
2004-04-15 |
2007-06-11 |
Alkermes Inc |
Dispositivo de liberacion continua base polimeros.
|
GB0417401D0
(en)
*
|
2004-08-05 |
2004-09-08 |
Controlled Therapeutics Sct |
Stabilised prostaglandin composition
|
US7080755B2
(en)
|
2004-09-13 |
2006-07-25 |
Michael Handfield |
Smart tray for dispensing medicaments
|
BRPI0614025A2
(pt)
|
2005-01-24 |
2012-12-25 |
Antares Pharma Inc |
injetores de jato
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
US8251947B2
(en)
|
2006-05-03 |
2012-08-28 |
Antares Pharma, Inc. |
Two-stage reconstituting injector
|
AU2007267338B2
(en)
*
|
2006-05-31 |
2013-04-04 |
Baxter Healthcare S.A. |
Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
|
GB0613333D0
(en)
|
2006-07-05 |
2006-08-16 |
Controlled Therapeutics Sct |
Hydrophilic polyurethane compositions
|
GB0613638D0
(en)
|
2006-07-08 |
2006-08-16 |
Controlled Therapeutics Sct |
Polyurethane elastomers
|
TWI436793B
(zh)
|
2006-08-02 |
2014-05-11 |
Baxter Int |
快速作用之乾密封膠及其使用和製造方法
|
PL2359808T3
(pl)
|
2006-08-09 |
2013-10-31 |
Intarcia Therapeutics Inc |
Osmotyczne systemy dostawcze i zespoły tłokowe
|
GB0620685D0
(en)
|
2006-10-18 |
2006-11-29 |
Controlled Therapeutics Sct |
Bioresorbable polymers
|
EP2114346B1
(en)
*
|
2007-01-25 |
2018-08-22 |
Hyperbranch Medical Technology, Inc. |
Applicators for multiple component formulations and the like
|
JP2010522196A
(ja)
*
|
2007-03-22 |
2010-07-01 |
アルカームズ,インコーポレイテッド |
コアセルベーション工程
|
CA2683610C
(en)
|
2007-04-23 |
2013-01-08 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
US20080317865A1
(en)
*
|
2007-06-20 |
2008-12-25 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
US8790698B2
(en)
|
2007-10-30 |
2014-07-29 |
Baxter International Inc. |
Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
JP5569398B2
(ja)
|
2008-02-29 |
2014-08-13 |
フェッローサン メディカル ディバイス エー/エス |
止血および/または創傷治癒を促進するための装置
|
ES2738539T3
(es)
|
2008-08-05 |
2020-01-23 |
Antares Pharma Inc |
Inyector de dosis múltiples
|
AU2010226442A1
(en)
|
2009-03-20 |
2011-10-13 |
Antares Pharma, Inc. |
Hazardous agent injection system
|
US9039783B2
(en)
*
|
2009-05-18 |
2015-05-26 |
Baxter International, Inc. |
Method for the improvement of mesh implant biocompatibility
|
AU2010262058B2
(en)
*
|
2009-06-16 |
2013-08-29 |
Baxter Healthcare S.A. |
Hemostatic sponge
|
KR101823699B1
(ko)
|
2009-09-28 |
2018-01-30 |
인타르시아 세라퓨틱스 인코포레이티드 |
실질 항정상태 약물 전달의 신속 확립 및/또는 종결
|
JP2013514093A
(ja)
|
2009-12-16 |
2013-04-25 |
バクスター・インターナショナル・インコーポレイテッド |
止血スポンジ
|
SA111320355B1
(ar)
|
2010-04-07 |
2015-01-08 |
Baxter Heathcare S A |
إسفنجة لايقاف النزف
|
IT1400323B1
(it)
*
|
2010-05-07 |
2013-05-24 |
Univ Degli Studi Torino |
Metodo per il rilascio controllato di un principio attivo
|
MX344402B
(es)
|
2010-06-01 |
2016-12-14 |
Baxter Int Inc * |
Proceso para elaborar composiciones hemostaticas secas y estables.
|
ES2682302T3
(es)
|
2010-06-01 |
2018-09-19 |
Baxter International Inc |
Proceso para la producción de composiciones hemostáticas secas y estables
|
WO2011151386A1
(en)
|
2010-06-01 |
2011-12-08 |
Baxter International Inc. |
Process for making dry and stable hemostatic compositions
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US9220660B2
(en)
|
2011-07-15 |
2015-12-29 |
Antares Pharma, Inc. |
Liquid-transfer adapter beveled spike
|
US8496619B2
(en)
|
2011-07-15 |
2013-07-30 |
Antares Pharma, Inc. |
Injection device with cammed ram assembly
|
MX356185B
(es)
|
2011-10-11 |
2018-05-17 |
Baxter Int |
Composiciones hemostaticas.
|
EP2766058B1
(en)
|
2011-10-11 |
2022-11-23 |
Baxter International Inc. |
Hemostatic compositions
|
CN103889447B
(zh)
|
2011-10-27 |
2015-11-25 |
巴克斯特国际公司 |
止血组合物
|
RU2657955C2
(ru)
|
2012-03-06 |
2018-06-18 |
Ферросан Медикал Дивайсиз А/С |
Контейнер под давлением, содержащий гемостатическую пасту
|
EP4186545A1
(en)
|
2012-04-06 |
2023-05-31 |
Antares Pharma, Inc. |
Needle assisted jet injection administration of testosterone compositions
|
WO2013169800A1
(en)
|
2012-05-07 |
2013-11-14 |
Antares Pharma, Inc. |
Injection device with cammed ram assembly
|
CA2874290C
(en)
|
2012-06-12 |
2020-02-25 |
Ferrosan Medical Devices A/S |
Dry haemostatic composition
|
ES2763633T3
(es)
|
2013-02-11 |
2020-05-29 |
Antares Pharma Inc |
Dispositivo de inyección por chorro asistido por aguja que tiene fuerza de disparo reducida
|
JP6030803B2
(ja)
|
2013-03-11 |
2016-11-24 |
アンタレス・ファーマ・インコーポレーテッド |
ピニオンシステムを有する用量注射器
|
WO2014202760A2
(en)
|
2013-06-21 |
2014-12-24 |
Ferrosan Medical Devices A/S |
Vacuum expanded dry composition and syringe for retaining same
|
EP3079731B1
(en)
|
2013-12-11 |
2018-08-08 |
Ferrosan Medical Devices A/S |
Dry composition comprising an extrusion enhancer
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
CA2960309A1
(en)
|
2014-10-13 |
2016-04-21 |
Ferrosan Medical Devices A/S |
Dry composition for use in haemostasis and wound healing
|
RU2705905C2
(ru)
|
2014-12-24 |
2019-11-12 |
Ферросан Медикал Дивайсиз А/С |
Шприц для удерживания и смешивания первого и второго веществ
|
MX2017015504A
(es)
|
2015-06-03 |
2018-05-15 |
Intarcia Therapeutics Inc |
Sistemas de colocacion y remoción de implante.
|
BR112017027695A2
(pt)
|
2015-07-03 |
2018-09-04 |
Ferrosan Medical Devices As |
seringa para retenção e mistura de primeira e segunda substâncias
|
PL3319596T3
(pl)
|
2015-07-09 |
2024-04-15 |
Uniwell Laboratories Llc |
Farmaceutyczne kompozycje
|
AU2017268161B2
(en)
|
2016-05-16 |
2020-03-12 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
AU2018206539A1
(en)
|
2017-01-03 |
2019-07-18 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
CN112368028A
(zh)
|
2018-05-09 |
2021-02-12 |
弗罗桑医疗设备公司 |
用于制备止血组合物的方法
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|